Straumann (SAUHY) Stock Price, News & Analysis

Company Overview

Straumann Group is a Switzerland-based dental technology company headquartered in Basel. Founded in 1954, the company develops, manufactures and distributes products used in tooth replacement, restorative dentistry and oral tissue regeneration. Its offerings are designed for dental professionals, laboratories and patients across a range of clinical applications.

The company’s portfolio includes dental implants, implant-supported prosthetics, biomaterials for bone and tissue regeneration, orthodontic aligners and digital dentistry solutions. Its brands include Straumann, Neodent, Anthogyr, Medentika, ClearCorrect and Dental Wings. Straumann also provides digital workflows, software and related equipment intended to support treatment planning, restorative design and dental laboratory production.

Straumann serves customers through direct operations and distribution networks in markets across Europe, North America, Latin America and the Asia-Pacific region. The company has expanded its business through product development and acquisitions, including investments in digital dentistry and clear-aligner treatment. Its shares trade in Switzerland, while American depositary shares are quoted in the over-the-counter market under the symbol SAUHY.

Key Stats

• Today's Range: $12.60 to $12.87
• 50-Day Range: $10.50 to $13.20
• 52-Week Range: $9.44 to $13.61
• Volume: 610,739 shs
• Average Volume: 160,124 shs
• Market Capitalization: $20.16 billion
• P/E Ratio: N/A
• Dividend Yield: 0.40%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Straumann Stock Analysis - MarketRank™

Straumann scored higher than 77% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Straumann has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 4 buy ratings, 1 hold rating, and 2 sell ratings.

Amount of Analyst Coverage

Straumann has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 20.00%

Earnings Growth

Earnings for Straumann are expected to grow by 20.00% in the coming year, from $0.40 to $0.48 per share.

Price to Earnings Growth Ratio

Straumann has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Straumann has a P/B Ratio of 7.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Straumann has been sold short.

Short Interest Ratio / Days to Cover

Straumann has a short interest ratio ("days to cover") of 0.11, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Straumann has recently decreased by 39.92%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Straumann has a dividend yield of 0.47%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Straumann does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Straumann will have a dividend payout ratio of 10.42% next year. This indicates that Straumann will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: N/A

News Sentiment

Straumann has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Straumann this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Straumann insiders have not sold or bought any company stock.

Percentage Held by Institutions

Straumann has minimal institutional ownership at this time.

Company Calendar

• Today: 11/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SAUHY
• Previous Symbol: OTCMKTS:SAUHY
• CIK: 1451279
• Web: www.straumann.com
• Phone: (161) 965-1111
• Fax: 41-61-965-1001
• Employees: 11,319
• Year Founded: 1954

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 26.33
• P/E Growth: 2.37
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $3.14 billion
• Price / Sales: 6.41
• Cash Flow: $0.46 per share
• Price / Cash Flow: 27.54
• Book Value: $1.64 per share
• Price / Book: 7.71

Miscellaneous

• Outstanding Shares: 1,594,552,000
• Free Float: N/A
• Market Cap: $20.16 billion
• Optionable: Not Optionable
• Beta: 1.50